Volume 88 Issue 27 | pp. 12-13
Issue Date: July 5, 2010

Losing Patent Fights In India

Because of the country’s strict definition of innovation, major drug firms struggle to win patent protection there
Department: Business, Government & Policy
Keywords: drug access, pharmaceutical patents, Indian generics

India’s patent office ruled in April that the patent on Valcyte, a Roche drug that prevents infection in transplant patients, is not valid in the country. With its decision, the patent office endorsed claims by Indian generic drug companies that Valcyte is not sufficiently innovative.

The Roche case is just the latest in a growing list of instances in which international drug companies are unable to secure protection in India for patented drugs they sell . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society